Cargando…
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
BACKGROUND: Despite the increased use of rituximab in treating pediatric patients with autoimmune diseases in the last decade, there are limited data on rituximab safety in those subjects who have a developing immune system. The objective of this study is to determine the prevalence of hypogammaglob...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712749/ https://www.ncbi.nlm.nih.gov/pubmed/31462263 http://dx.doi.org/10.1186/s12969-019-0365-y |